These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

933 related items for PubMed ID: 22427472

  • 1. The impact of HLA-E polymorphisms in graft-versus-host disease following HLA-E matched allogeneic hematopoietic stem cell transplantation.
    Hosseini E, Schwarer AP, Ghasemzadeh M.
    Iran J Allergy Asthma Immunol; 2012 Mar; 11(1):15-21. PubMed ID: 22427472
    [Abstract] [Full Text] [Related]

  • 2. The impact of HLA-E polymorphisms on relapse following allogeneic hematopoietic stem cell transplantation.
    Hosseini E, Schwarer AP, Jalali A, Ghasemzadeh M.
    Leuk Res; 2013 May; 37(5):516-9. PubMed ID: 23395341
    [Abstract] [Full Text] [Related]

  • 3. Clinical significance of HLA-E*0103 homozygosity on survival after allogeneic hematopoietic stem-cell transplantation.
    Danzer M, Polin H, Pröll J, Haunschmid R, Hofer K, Stabentheiner S, Hackl C, Kasparu H, König J, Hauser H, Binder M, Weiss R, Gabriel C, Krieger O.
    Transplantation; 2009 Aug 27; 88(4):528-32. PubMed ID: 19696636
    [Abstract] [Full Text] [Related]

  • 4. Degree of predicted minor histocompatibility antigen mismatch correlates with poorer clinical outcomes in nonmyeloablative allogeneic hematopoietic cell transplantation.
    Larsen ME, Kornblit B, Larsen MV, Masmas TN, Nielsen M, Thiim M, Garred P, Stryhn A, Lund O, Buus S, Vindelov L.
    Biol Blood Marrow Transplant; 2010 Oct 27; 16(10):1370-81. PubMed ID: 20353833
    [Abstract] [Full Text] [Related]

  • 5. Role of killer immunoglobulin-like receptor-ligand interactions in human leukocyte antigen-matched sibling hematopoietic stem cell transplantation.
    Kanga U, Mourya M, Seth T, George J, Sood P, Sharma R, Saxena A, Mehra NK.
    Transplant Proc; 2012 May 27; 44(4):919-21. PubMed ID: 22564585
    [Abstract] [Full Text] [Related]

  • 6. Homozygous status for HLA-E*0103 confers protection from acute graft-versus-host disease and transplant-related mortality in HLA-matched sibling hematopoietic stem cell transplantation.
    Tamouza R, Busson M, Rocha V, Fortier C, Haddad Y, Brun M, Boukouaci W, Bleux H, Socié G, Krishnamoorthy R, Toubert A, Gluckman E, Charron D.
    Transplantation; 2006 Dec 15; 82(11):1436-40. PubMed ID: 17164714
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Impact of human leucocyte antigen mismatch on graft-versus-host disease and graft failure after reduced intensity conditioning allogeneic haematopoietic stem cell transplantation from related donors.
    Teshima T, Matsuo K, Matsue K, Kawano F, Taniguchi S, Hara M, Hatanaka K, Tanimoto M, Harada M, Nakao S, Abe Y, Wake A, Eto T, Takemoto Y, Imamura M, Takahashi S, Ishida Y, Kanda Y, Kasai M, Takaue Y.
    Br J Haematol; 2005 Aug 15; 130(4):575-87. PubMed ID: 16098073
    [Abstract] [Full Text] [Related]

  • 9. Glutathione S-transferase A1 polymorphisms and acute graft-vs.-host disease in HLA-matched sibling allogeneic hematopoietic stem cell transplantation.
    Kim I, Keam B, Lee KH, Kim JH, Oh SY, Ra EK, Yoon SS, Park SS, Kim CS, Park S, Hong YC, Kim BK.
    Clin Transplant; 2007 Aug 15; 21(2):207-13. PubMed ID: 17425746
    [Abstract] [Full Text] [Related]

  • 10. Cytomegalovirus reactivation after matched sibling donor reduced-intensity conditioning allogeneic hematopoietic stem cell transplant correlates with donor killer immunoglobulin-like receptor genotype.
    Sobecks RM, Askar M, Thomas D, Rybicki L, Kalaycio M, Dean R, Avery R, Mossad S, Copelan E, Bolwell BJ.
    Exp Clin Transplant; 2011 Feb 15; 9(1):7-13. PubMed ID: 21605017
    [Abstract] [Full Text] [Related]

  • 11. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL.
    Dan Med Bull; 2007 May 15; 54(2):112-39. PubMed ID: 17521527
    [Abstract] [Full Text] [Related]

  • 12. Related HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion: observations of a single Chinese center.
    Huang X, Liu D.
    Clin Transpl; 2011 May 15; ():237-45. PubMed ID: 22755417
    [Abstract] [Full Text] [Related]

  • 13. Effect of major histocompatibility complex haplotype matching by C4 and MICA genotyping on acute graft versus host disease in unrelated hematopoietic stem cell transplantation.
    Park Y, Cheong JW, Park MH, Kim MS, Kim JS, Kim HS.
    Hum Immunol; 2016 Feb 15; 77(2):176-83. PubMed ID: 26602146
    [Abstract] [Full Text] [Related]

  • 14. Long-term outcomes of HLA-matched sibling compared with mismatched related and unrelated donor hematopoietic stem cell transplantation for chronic phase chronic myelogenous leukemia: a single institution experience in China.
    Liu QF, Xu XJ, Chen YK, Sun J, Zhang Y, Fan ZP, Xu D, Jiang QL, Wei YQ, Huang F, Feng R, Liu XL, Xu B, Meng FY.
    Ann Hematol; 2011 Mar 15; 90(3):331-41. PubMed ID: 20872002
    [Abstract] [Full Text] [Related]

  • 15. The predictive value of helper T lymphocyte precursor frequencies for graft-versus-host disease and graft-versus-leukaemia effects in allogeneic bone marrow transplantation.
    Russell CA, Heilmann C, Madsen HO, Vindeløv LL.
    Bone Marrow Transplant; 2001 May 15; 27(9):949-58. PubMed ID: 11436105
    [Abstract] [Full Text] [Related]

  • 16. KIR genes and KIR ligands affect occurrence of acute GVHD after unrelated, 12/12 HLA matched, hematopoietic stem cell transplantation.
    Ludajic K, Balavarca Y, Bickeböller H, Rosenmayr A, Fae I, Fischer GF, Kouba M, Pohlreich D, Kalhs P, Greinix HT.
    Bone Marrow Transplant; 2009 Jul 15; 44(2):97-103. PubMed ID: 19169284
    [Abstract] [Full Text] [Related]

  • 17. Activating killer immunoglobulin-like receptor incompatibilities enhance graft-versus-host disease and affect survival after allogeneic hematopoietic stem cell transplantation.
    Giebel S, Nowak I, Dziaczkowska J, Czerw T, Wojnar J, Krawczyk-Kulis M, Holowiecki J, Holowiecka-Goral A, Markiewicz M, Kopera M, Karolczyk A, Kyrcz-Krzemien S, Kusnierczyk P.
    Eur J Haematol; 2009 Oct 15; 83(4):343-56. PubMed ID: 19500138
    [Abstract] [Full Text] [Related]

  • 18. Successful prevention of acute graft-versus-host disease using low-dose antithymocyte globulin after mismatched, unrelated, hematopoietic stem cell transplantation for acute myelogenous leukemia.
    Kim HJ, Min WS, Cho BS, Eom KS, Kim YJ, Min CK, Lee S, Cho SG, Jin JY, Lee JW, Kim CC.
    Biol Blood Marrow Transplant; 2009 Jun 15; 15(6):704-17. PubMed ID: 19450755
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.